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To the Editors:
We have read with interest the letter by Dr. Vogt and
colleagues, who report on their clinical experience with
allografts. Our clinical experience in using cryopreserved
arterial allografts dates from 1994 (23 bypass procedures
performed from October 1994 to December 1996). Our
cryopreservation protocol is similar to the one of the
European Homograft Bank in Brussels. The exact origin
of early degeneration of implanted arterial allografts (rup-
ture and dilation) is difficult to establish. Hypotheses of
rejection or septic necrosis cannot be discarded. However,
a possible link to the cryopreservation process has to be
taken into consideration when an allograft rupture is
observed a few hours after its implantation.
At this time, only a few studies are available concern-
ing cryopreservation ofvascular structures. An experimen-
tal study that is aimed at optimizing these techniques has
been ongoing in Nancy for the past 3 years. This study
suggests that cryopreservation could lead to potentially
deleterious lesions through extracellular water crystalliza-
tion and ice crystal agglutination. These phenomena are
partly related to the temperature gradient. To minimize
these lesions quicker congelation, and also new cryopro-
tectants, are currently under evaluation.
The clinical interest of arterial allografts is not ques-
tionable at this time, but we believe that further funda-
mental studies have to be conducted to improve the
preservation process. Although unable to inform us about
the outcome of implanted grafts, these studies should
help us to provide our patients with grafts of optimal
quality.
Bertrand Lehalle, MD
Jean-Franfois Stoltz, MD, PhD
Nancy Teaching Hospital
University of Nancy
France
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Regarding "Impact of a critical pathway on the
results of carotid endarterectomy in a tertiary care
university hospital: Effect of methods on outcome"
To the Editors:
We applaud the efforts of Dardik and colleagues
reported recently in the Journal (J Vasc Surg
1997;26:186-92). We wish to point out that critical path-
ways have been proposed not only to decrease hospital
costs but also to possibly decrease postoperative complica-
tions. In addition, similar to their hospital, ours is a ter-
tiary care referral center where approximately only half to
two thirds of patients can be entered into a critical path-
way because of far distances patients traveled, emergency
cases, or concomitant surgery. 1 Nonetheless, as many
other progressive vascular surgical groups are doing, our
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target discharge day for patients who undergo elective
carotid endarterectomy is the first postoperative day,
patients are now being transferred to the floor the day of
surgery, and decisions concerning operative intervention
are made on the basis of duplex ultrasound without arte-
riography.
The main concern regarding the report by Dardik and
associates is that their target discharge date and other fac-
tors in their critical pathway protocol were very conserva-
tive, and therefore any differences in length of stay and
costs were predetermined to be minimal. Will they now
eliminate these pathways because they did not document
any clear advantages of using them? We wholeheartedly
agree with their sentiment that third-party payers should
realize that especially at tertiary care centers only a limited
number of patients who undergo vascular surgery will be
candidates for critical pathways.
Keith D. Catligaro, MD
Pennsylvania Hospital
700 Spruce St., Suite 101
Philadelphia, PA 19106
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Reply
To the Editors:
We appreciate the interest in our study conveyed in
Dr. Calligaro's letter and the opportunity afforded by the
Journal to respond. There are several points worthy of
comment.
First, we disagree with the proposition of our col-
league that a primary purpose of critical pathways is to
"possibly decrease postoperative complications." Our
carotid endarterectomy (CEA) critical pathway, like the
dozens of other critical pathways implemented within our
surgical department, was developed to guide the postop-
erative care of this patient population so that we may con-
tinue to improve that care and provide it in an increasing-
ly cost-effective fashion. There was no expectation that a
CEA critical pathway might reduce postoperative morbid-
ity. Indeed, we believe it is axiomatic that the develop-
ment ofpostoperative complications is most directly influ-
enced by patient comorbidity and the technical conduct of
the operation, rather than some standardized postopera-
tive order sheet.
Second, Dr. Calligaro has observed that our critical
pathway goal of discharge on the third postoperative day
is "conservative" by current practice standards. We agree
and clearly acknowledged this point in the paper. As noted
in the manuscript, this initial CEA critical pathway was
